Report Outlines the Realities of Asthma Care in the United States and the Policy and Clinical Interventions that May Provide Improvements to Current Asthma Care

Being in-network with Aetna and Cigna will now allow Clarity Clinic to expand access to their Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs, ensuring more individuals receive the high-quality care they need for their recovery journey.

Educational conference focused on diagnosis, research and treatment of rare neuroimmune disorders

Quest International’s Expanded FCA Resources Offer Medical Device OEMs Timely, Reliable Support Amid Rising FDA Recalls

ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy.

Training for the proprietary program is aimed at implementing the latest evidenced-based approaches to dementia care amid the growing numbers of Americans affected.

IRB approval on track as scheduled

Next step is obtaining all regulatory approvals, followed by site initiation visit

VELDONA significantly increases unstimulated whole salivary flow in prior Phase 3 studies

Dr. Naba Sharif set to lead initiatives for enhanced allergy and asthma care for New Jersey residents.

REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and Omega-3s for Enhanced Memory and Brain Function in Aging Adults. Recognized by Japan as a 'Food with Functional Claims,' REMORY is FDA-Notified, Setting a New Standard in Natural Cognitive Support.

Secured multi-regional patent assets, strengthening Ainos' AI Nose technology.

Expanded VELDONA® patent portfolio with a new invention patent for treatments and preventions for coronavirus infections.

Progressed clinical trials for VELDONA®, including new studies on Sjögren's syndrome and HIV-related oral warts.

Third Holland Foundation Center of Excellence To Be Established

PRECEDE Study Aims to Increase Early Detection in Pancreatic Cancer

Leading podiatrists renew their commitment to public health and community involvement, championing the annual cancer event for the past 22 years.  

Strengthens AI Nose Gas Sensing Technology with Additional Exclusively Licensed Patents

Secures Exclusive Rights to Breakthrough Nitrogen-Oxygen Separation Technology with Superior Energy Efficiency and Ultra-Low Carbon Emissions, Advancing Sustainable Medical Practices

Prioritizing VELDONA®'s development for oral warts in HIV+ patients and Sjogren's syndrome

Burgeoning pet care market also presents growth opportunities for VELDONA®

Compassion Center and SIDHE sound the alarm on a growing crisis in the psychedelic market, warning consumers of dangerous, mislabeled products and advocating for urgent reforms to ensure transparency, safety, and informed use of these powerful substances. Join the movement towards ethical, responsible psychedelic experiences, backed by science and tradition.

Ainos pioneers AI-powered digital nose technology with VOC detection breakthroughs for early disease diagnosis, industrial safety, and human-like sensory capabilities in robots

VELDONA^® low-dose oral interferon technology demonstrates huge potential in in viral, autoimmune, and veterinary treatments